A single dose of psilocybin could have enduring advantages for folks with main depressive dysfunction, in keeping with a randomized scientific trial revealed Thursday within the Journal of the American Medical Affiliation.
A number of prior research have prompt that psilocybin, the psychedelic compound produced by sure varieties of mushrooms, could possibly be a promising option to deal with main despair in folks for whom antidepressants or counseling aren’t efficient. However these research principally centered on short-term outcomes, whereas the brand new JAMA examine checked out psilocybin’s efficacy as much as six weeks after the administration of a single dose of psilocybin.
“It’s thrilling to see one other examine that’s popping out that’s including to the proof base suggesting potential efficacy of psilocybin for despair, amongst different circumstances,” mentioned Greg Fonzo, an assistant professor and co-director for the Middle for Psychedelic Analysis and Remedy on the College of Texas at Austin’s Dell Medical College, who was not concerned within the examine.
Get limitless entry to award-winning journalism and unique occasions.
Subscribe